Abstract:This study was conducted to investigate the role of different homocysteine metabolism-related vitamin (HMRV) levels in the correlation between hyperhomocysteinemia (HHCY) and ischemic stroke (IS) subtypes. Three hundred and forty-eight IS patients manifesting different vascular subtypes were subclassified on the basis of HMRV deficiencies. Correlation between HHCY and IS subtypes was investigated in all the subgroups. In this study, HHCY was significantly correlated with the IS subtypes in large artery atherosclerosis (OR 1.126, 95%CI: 1.051 +/- 1.206, P = 0.001) and small artery occlusion (OR 1.105, 95%CI: 1.023 +/- 1.193, P = 0.012). Subgroup analysis revealed a correlation between HHCY and IS subgroup (OR 1.201, 1.178, 95%CI: 1.081 +/- 1.334, 1.058 +/- 1.313, P = 0.001, P = 0.003, respectively) in HMRV deficiency, but not significantly with the IS subgroup in normal HMRV levels. Serum vitamin B12 concentrations are inversely correlated with both IS subtypes in HMRV deficiency subgroups (OR 0.992, 0.995, 95%CI: 0.987 +/- 0.996, 0.991 +/- 0.999, P < 0.001, P = 0.007, respectively), which may contribute to HHCY incidence in these populations. The correlation between HHCY and IS subtypes is affected by HMRV levels in this case-control study. Our findings are helpful to understand the inconsistency in prior homocysteine studies. Serum vitamin B12 levels may play a critical role in HHCY incidence in this Chinese population.Cerebrovascular disease has emerged as the leading cause of disability and mortality in both urban and rural areas of China (Neurology branch of Chinese Medical Association 2015). Ischemic stroke (IS) constitutes 60% to 80% of all cerebrovascular disease (Neurology branch of Chinese Medical Association 2014). Among a variety of risk factors, hyperhomocysteinemia (HHCY) has been closely correlated with IS due to intracranial small-vessel disease and extracranial large-artery disease (Selhub et al. 1995; Eikelboom et al. 2000; Alvarez et al. 2012; Jeon et al. 2014). However, the failure to lower homocysteine (HCY) via homocysteine metabolism-related vitamin (HMRV, including folic acid and vitamin B12 but not vitamin B6 in this study) supplementation to reduce stroke morbidity questions the role of HCY as a risk factor for stroke (Lonn et al. 2006; Hankey et al. 2010). Theoretically, HMRV supplementation merely lowers the incidence of stroke induced by HHCY resulting from HMRV deficiency, whereas HHCY-induced stroke concomitant with normal HMRV levels may be refractory to treatment. The correlation between HCY varying with HMRV levels and IS subtypes is still unclear. In this study, we investigated the impact of variation in HMRV levels on the correlation between HHCY and IS subtypes in 348 acute IS patients with large and small vessel diseases. We sought to determine the factors underlying the conflicting results associated with lowering HCY by HMRV supplementation to reduce stroke incidence.

Association Between Homocysteine and Multivascular Atherosclerosis in Stroke-Related Vascular Beds Determined by Three-Dimensional Magnetic Resonance Vessel Wall Imaging

Elevated Homocysteine As an Independent Risk for Intracranial Atherosclerotic Stenosis

Relationship between plasma homocysteine level and stroke

Association Between Homocysteine and Cerebral Small Vessel Disease: A Meta-Analysis

Association of Homocysteine with Acute Stroke and Its Subtypes in the Chinese Population

Association of Homocysteine with Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients

A6282 Association of Homocysteine with Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients

Homocysteine is Associated with the Development of Cerebral Small Vessel Disease: Retrospective Analyses from Neuroimaging and Cognitive Outcomes

Serum level of homocysteine is correlated to carotid artery atherosclerosis in Chinese with ischemic stroke

Associations Between Carotid Plaques and White Matter Hyperintensities in Cerebral Small Vessel Disease

The relationship between homocysteine and carotid atherosclerosis as well as cerebral infarction

High Plasma Homocysteine Levels Contribute to the Risk of Stroke Recurrence and All-Cause Mortality in a Large Prospective Stroke Population.

Relationship between plasma homocysteine and carotid atherosclerotic plaques in patients with ischemic cerebrovascular disease

Atherosclerosis in Stroke-Related Vascular Beds and Stroke Risk: A 3-D MR Vessel Wall Imaging Study

The Relationship Between the Plasma Homocysteine and Intracranial Artery Stenosis in Patients with Cerebral Infarction

The Association Between Homocysteine and Ischemic Stroke Subtypes in Chinese

Association between homocysteine and white matter hyperintensities in asymptomatic intracranial arterial stenosis: results from a population-based study

Association Between Hyperhomocysteinemia and Stroke with Atherosclerosis and Small Artery Occlusion Depends on Homocysteine Metabolism-Related Vitamin Levels in Chinese Patients with Normal Renal Function

Homocysteine and Carotid Plaque Stability: A Cross-Sectional Study in Chinese Adults

Investigatigating of mechanism of hyperhomocysteinemia leading to cerebrovascular disease

Co-existing Hypertension and Hyperhomocysteinemia Increases the Risk of Carotid Vulnerable Plaque and Subsequent Vascular Event: an MR Vessel Wall Imaging Study.